Carotid Ultrasound‐Based Plaque Score for the Allocation of Aspirin for the Primary Prevention of Cardiovascular Disease Events: The Multi‐Ethnic Study of Atherosclerosis and the Atherosclerosis Risk in Communities Study
Journal of the American Heart Association · 18.06.2024 · 13 (12)
DOI: 10.1161/jaha.123.034718 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 18.06.2024. Verfasst von Omar Dzaye und 10 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University Baltimore MD USA. Hauptthemen laut MEDLINE: Aspirin, Primary Prevention, Plaque, Atherosclerotic, Carotid Artery Diseases. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Coronary artery calcium testing using noncontrast cardiac computed tomography is a guideline‐indicated test to help refine eligibility for aspirin in primary prevention. However, access to cardiac computed tomography remains limited, with carotid ultrasound used much more often internationally. We sought to update the role of aspirin allocation in primary prevention as a function of subclinical carotid atherosclerosis. Methods and Results The study included 11 379 participants from the MESA (Multi‐Ethnic Study of Atherosclerosis) and ARIC (Atherosclerosis Risk in Communities) studies. A harmonized carotid plaque score (range, 0–6) was derived using the number of anatomic sites with plaque from the left and right common, bifurcation, and internal carotid artery on ultrasound. The 5‐year number needed to treat and number needed to harm as a function of the carotid plaque score were calculated by applying a 12% relative risk reduction in atherosclerotic cardiovascular disease (ASCVD) events and 42% relative increase in major bleeding events related to aspirin use, respectively. The mean age was 57 years, 57% were women, 23% were Black, and the median 10‐year ASCVD risk was 12.8%. The 5‐year incidence rates (per 1000 person‐years) were 5.5 (4.9–6.2) for ASCVD and 1.8 (1.5–2.2) for major bleeding events. The overall 5‐year number needed to treat with aspirin was 306 but was 2‐fold lower for individuals with carotid plaque versus those without carotid plaque (212 versus 448). The 5‐year number needed to treat was less than the 5‐year number needed to harm when the carotid plaque score was ≥2 for individuals with ASCVD risk 5% to 20%, whereas the presence of any carotid plaque demarcated a favorable risk–benefit for individuals with ASCVD risk >20%.
Conclusions
Quantification of subclinical carotid atherosclerosis can help improve the allocation of aspirin therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease Johns Hopkins University Baltimore MD USA.
- Emory Center for Heart Disease Prevention Emory University School of Medicine Atlanta GA USA.
- Division of Cardiovascular Prevention and Wellness Houston Methodist DeBakey Heart & Vascular Center Houston TX USA.
- Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore MD USA.
- Department of Medicine and Aging, and Center for Advanced Studies and Technology "G. d'Annunzio" University of Chieti Chieti Italy.
- Council of Epidemiology and Cardiovascular Prevention Argentine Society of Cardiology Buenos Aires Argentina.
ORCID-Profile: Omar Dzaye, Alexander C Razavi, Zeina A Dardari, Khurram Nasir, Kunihiro Matsushita, Yejin Mok, Francesca Santilli, Augusto María Lavalle Cobo, Amer M Johri, Michael J Blaha
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Dzaye, O., Razavi, A. C., Dardari, Z. A., Nasir, K., Matsushita, K., Mok, Y., Santilli, F., Lavalle Cobo, A. M., Johri, A. M., Albrecht, G., & Blaha, M. J. (2024). Carotid Ultrasound‐Based Plaque Score for the Allocation of Aspirin for the Primary Prevention of Cardiovascular Disease Events: The Multi‐Ethnic Study of Atherosclerosis and the Atherosclerosis Risk in Communities Study. Journal of the American Heart Association, 13(12). https://doi.org/10.1161/jaha.123.034718
Vancouver
Dzaye O, Razavi AC, Dardari ZA, Nasir K, Matsushita K, Mok Y, et al. Carotid Ultrasound‐Based Plaque Score for the Allocation of Aspirin for the Primary Prevention of Cardiovascular Disease Events: The Multi‐Ethnic Study of Atherosclerosis and the Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. 2024;13(12). doi:10.1161/jaha.123.034718
BibTeX
@article{Dzaye2024,
author = {Dzaye, Omar and Razavi, Alexander C and Dardari, Zeina A and Nasir, Khurram and Matsushita, Kunihiro and Mok, Yejin and Santilli, Francesca and Lavalle Cobo, Augusto María and Johri, Amer M and Albrecht, Gerhard and Blaha, Michael J},
title = {Carotid Ultrasound‐Based Plaque Score for the Allocation of Aspirin for the Primary Prevention of Cardiovascular Disease Events: The Multi‐Ethnic Study of Atherosclerosis and the Atherosclerosis Risk in Communities Study},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {12},
doi = {10.1161/jaha.123.034718}
}
EUVIMED